Why is the Ramsay (ASX:RHC) share price so volatile today?

COVID is hitting Ramsay's operations…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price has pulled back from its intraday highs in afternoon trade.

At the time of writing, the private hospital operator's shares are up 0.5% to $68.00.

This compares to a 2% gain for the Ramsay share price in earlier trade.

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused

Image source: Getty Images

What did Ramsay announce?

This afternoon Ramsay released an update in relation to the impact that COVID-19 restrictions are having on its operations.

It notes that the NSW Ministry of Health will introduce restrictions on non-urgent overnight Category 2 and Category 3 elective surgeries at all private hospitals in the state effective 10 January.

Category 2 admission relates to a condition which is not likely to deteriorate quickly or become an emergency within 90 days. Whereas a Category 3 admission is unlikely to deteriorate quickly and has little potential to become an emergency within 365 days.

In addition to this, Ramsay highlights that similar changes were made by the Victorian Department of Health and Human Services (DHHS) to surgical restrictions on 6 January. Elective surgery is now restricted to urgent elective surgery procedures.

Further, neither the DHHS nor the NSW Ministry of Health have provided a date for when these restrictions will end and Ramsay will be able to return to business as usual.

What will the impact be?

Ramsay has warned that these and previous surgical restrictions will have a material impact on its earnings in FY 2022. For example, it notes that in the first quarter, COVID related disruptions and costs impacted its Australian earnings by $55 million.

And while January is the seasonally quietest month of the year in the Australian business, it remains unclear when the current wave of Omicron cases will subside and Ramsay will be able to operate as normal again. This could see the restrictions creep into busier months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A doctor and an elderly couple sit at a desk and look at a lung scan uploaded.
Healthcare Shares

Why did 4DMedical shares charge higher today, then drop?

The company's key technology has received a big tick.

Read more »

Business woman working from home with stock market chart showing percent change on her laptop screen.
Healthcare Shares

Should I invest $10,000 in CSL shares before the end of May?

This ASX healthcare giant has fallen hard, but the lower price and improving dividend appeal make it worth another look.

Read more »

A woman wakes up after sleeping soundly, stretching her arms high sitting in bed.
Healthcare Shares

Why this fallen ASX 200 blue chip could be a strong buy

I think the market may be underestimating the durability of this healthcare business.

Read more »

Female pharmacist smiles with a digital tablet.
Broker Notes

3 reasons to buy Sigma Healthcare shares today

A leading analyst expects “impressive growth” from Sigma Healthcare shares.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news.
Healthcare Shares

Could this fallen ASX 200 stock be a once-in-a-decade opportunity?

The valuation now looks far more interesting for a healthcare stock with a global leadership position.

Read more »

Hand dropping a mic.
Healthcare Shares

Pro Medicus shares jump as massive US contract win turns heads

Pro Medicus shares are rocketing after a major US win.

Read more »

Two business people shaking hands in an office
Healthcare Shares

Pro Medicus inks $90m contract

Pro Medicus signs a major $90m contract with Beth Israel Lahey Health, boosting its North American growth outlook.

Read more »

Shattered investor with head in hands, with ASX chart in the background.
Healthcare Shares

CSL shares crash, but is a comeback looming?

Has the market become too pessimistic about Australia's biotech giant?

Read more »